latest update:
[TrialBase DB]

trial summary · NCT07818564

Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation

Trial record from the TrialBase DB dataset, status RECRUITING, condition Phase I, sponsored by Brown University. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07818564phase PHASE1enrollment 24start 2026-11

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The primary aim of this phase I mechanistic pilot study is to evaluate the effects of psilocybin on aspects of cognition in healthy adult volunteers. Up to 24 participants will receive a single dose of either psilocybin or inert placebo, and they will be asked to complete several computer-based behavioral tasks measuring features of learning, belief updating, and abstraction. Participants will also complete measures of subjective experience and expectancy, as well as semi-structured interviews at follow up, to assess whether experience correlates with behavior. This is a Voluntary Submission.

Source record: https://clinicaltrials.gov/study/NCT07818564

Facts

registry idNCT07818564
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE1
study typeINTERVENTIONAL
lead conditionPhase I
sponsorBrown University
sponsor classOTHER
enrollment24
start date2026-11
primary completion2027-11
completion2027-11
results postednot reported

Conditions

  • Phase I

Interventions

  • Psilocybin (Usona Institute)
  • Inactive Placebo (Usona Institute)

Countries

  • United States

Intervention types: DRUG

Work with this record